Congo, The Democratic Republic of the
News Category
Vinhomes Expands Integrated City-Building Model from Vietnam to Global Markets
Vinhomes is scaling its integrated ecosystem approach to urban development from Vietnam into Africa, South Asia, and Australia, positioning itself to ...

NanoViricides Registers Phase II Ebola Trial for NV-387 Oral Gummies in DRC
NanoViricides has registered its Phase II Ebola trial for NV-387 Oral Gummies in the Democratic Republic of Congo, marking a potential advancement in ...

NanoViricides Prepares for Phase II Ebola Trial of NV-387 Oral Gummies in the DRC
NanoViricides has received regulatory approval to begin a Phase II trial of its oral antiviral NV-387 for Ebola in the Democratic Republic of Congo, w...

GeoVax Offers Hemorrhagic Fever Expertise Amid Fast-Growing Ebola Outbreak
As the Bundibugyo Ebola outbreak escalates in the DRC, GeoVax highlights its MVA-based vaccine candidates and expertise, positioning itself for potent...

NanoViricides Receives Regulatory Approval for Phase II Ebola Trial of NV-387 Oral Gummies in DRC
NanoViricides has received regulatory approval from the DRC to begin a Phase II trial of its oral antiviral NV-387 for Ebola, potentially offering a m...

NanoViricides Awaits Regulatory Decision on Ebola Trial for NV-387 Oral Gummies
NanoViricides has submitted an application to begin a Phase II trial of its oral antiviral NV-387 for Bundibugyo ebolavirus in the DRC, where no appro...

NanoViricides Seeks Approval for Phase II Ebola Trial in DRC Amid Ongoing Outbreak
NanoViricides has applied to the DRC's regulatory agency to start a Phase II trial of its oral antiviral NV-387 for the Bundibugyo ebolavirus outbreak...

NanoViricides Receives Ethics Approval for Phase II Ebola Trial in DRC
NanoViricides has received National Ethics Committee approval in the Democratic Republic of the Congo for a Phase II clinical trial of its oral NV-387...

Congo’s Copper Mining Unaffected by Middle East Crisis, Exports Grow
The Democratic Republic of Congo's copper and cobalt production remains unaffected by Middle East unrest, with exports growing, offering lessons for o...

NanoViricides Advances NV-387 Toward Phase II Trial for Bundibugyo Ebola in DRC
NanoViricides progresses its oral gummies formulation of NV-387 toward a Phase II trial for the Bundibugyo ebolavirus outbreak in the DRC, where no ap...

NanoViricides Ships NV-387 Oral Gummies to DRC for Phase II MPox Trial
NanoViricides has shipped NV-387 Oral Gummies to the Democratic Republic of Congo for a Phase II clinical trial targeting MPox, with potential implica...

NanoViricides Receives DRC Approval to Advance Phase II Ebola Trial for Oral Antiviral Gummies
NanoViricides announced DRC approval to proceed with a Phase II trial of NV-387 Oral Gummies for Bundibugyo ebolavirus, marking a potential breakthrou...

Redwood AI Corp. Signs LOI for AI-Enabled Pathogen Surveillance Initiative in East Africa
Redwood AI Corp. has signed a letter of intent to develop an AI-driven pathogen tracking and outbreak intelligence initiative in Central and East Afri...

Trident Digital Tech Launches TDTHAI Enterprise AI Platform for Asia-Pacific Markets
Trident Digital Tech Holdings Ltd. announced the launch of TDTHAI, an AI platform targeting enterprise and government clients in Asia-Pacific, marking...

CDC Expands Ebola Travel Ban to Include Green Card Holders
The U.S. CDC has extended its travel ban on individuals who have recently visited Uganda, South Sudan, and the DRC to include green card holders, aimi...

NanoViricides Highlights NV-387 as Potential Candidate for Bundibugyo Ebola Outbreak
NanoViricides announces that its broad-spectrum antiviral NV-387 warrants evaluation for the Bundibugyo Ebola outbreak due to its host-targeted mechan...

NanoViricides Highlights Broad-Spectrum Antiviral Candidate Amid Ebola Outbreak
NanoViricides emphasizes the potential of its oral drug candidate NV-387 as a broad-spectrum antiviral for Ebola and other filoviruses, positioning it...

NanoViricides Advances Broad-Spectrum Antiviral NV-387 Toward Phase II Trials for MPox
NanoViricides reported progress on NV-387, including regulatory approval for Phase II MPox trials in the DRC and FDA orphan drug designation for measl...

Iran Conflict Disrupts Chemical Supply for DRC’s Cobalt and Copper Miners
The ongoing conflict in Iran is disrupting the supply of essential processing chemicals for cobalt and copper miners in the Democratic Republic of Con...

NanoViricides to Initiate Phase II MPox Trial in Democratic Republic of Congo
NanoViricides announced the upcoming Phase II clinical trial of its antiviral candidate NV-387 for MPox in the DRC, with site preparation and staff tr...

US Firm Virtus Minerals Acquires DRC Lithium and Cobalt Producer Chemaf
Virtus Minerals, a US-based critical minerals firm, acquires Chemaf, a DRC miner of lithium and cobalt, signaling a strategic move to secure supply ch...

Easy Environmental Solutions capitalizes on nitrogen shortage with Terreplenish microbial solution
Easy Environmental Solutions reports strong first quarter momentum driven by its Terreplenish organic fertilizer, which addresses global nitrogen shor...

NanoViricides to Present at NIBA Conference as NV-387 Oral Gummies Manufacturing Completed
NanoViricides announced the completion of manufacturing for its NV-387 Oral Gummies drug product and will present progress at the NIBA Investment Conf...

DR Congo Resumes Cobalt Exports After 10-Month Ban, Highlighting Supply Chain Vulnerabilities
The Democratic Republic of Congo has ended its 10-month ban on cobalt exports, underscoring the global market's reliance on a single country for criti...

Micropolis AI Robotics Signs $9.3M Agreement With AfricAI to Develop UGVs for African Markets
Micropolis AI Robotics has entered a $9.3 million development and distribution deal with AfricAI to design three customized unmanned ground vehicles f...

NanoViricides President Discusses Broad-Spectrum Antiviral Platform and NV-387 Progress in Mission Matters Podcast
NanoViricides President Dr. Anil Diwan highlighted the company's nanoviricide platform and lead candidate NV-387's potential as an empirical therapy f...

Democratic Republic of Congo's Cobalt Export Suspension Threatens Global Supply by 2026
The DRC's suspension of cobalt exports and shift to a quota system could create a significant deficit in global cobalt supply by 2026-2027, impacting ...

Sekur Private Data Targets DRC Expansion Following Africa Digital Innovation Summit Participation
Sekur Private Data Ltd. is expanding secure communications in the Democratic Republic of Congo, leveraging rising demand for encrypted solutions amid ...
